(Q38635553)

5 September 2017

title

Trends in the Mortality of Hepatocellular Carcinoma in the United States (English)

1 reference

5 September 2017

main subject

hepatocellular carcinoma

1 reference

Dmitry Tumin

2

0 references

Timothy Pawlik

10

object named as

Timothy M Pawlik

1 reference

5 September 2017

1

Eliza W Beal

1 reference

5 September 2017

Ali Kabir

3

1 reference

5 September 2017

Dimitrios Moris

4

1 reference

5 September 2017

Xu-Feng Zhang

5

1 reference

5 September 2017

Jeffery Chakedis

6

1 reference

5 September 2017

Kenneth Washburn

7

1 reference

5 September 2017

Sylvester Black

8

1 reference

5 September 2017

Carl M Schmidt

9

1 reference

5 September 2017

publication date

7 August 2017

1 reference

Journal of Gastrointestinal Surgery

5 September 2017

published in

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-017-3526-7

5 September 2017

exact match

0 references

cites work

Global cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Forecasting hepatocellular carcinoma mortality in Taiwan using an age-period-cohort model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Validation and limitation of age-period-cohort model in simulating mortality due to hepatocellular carcinoma from 1940 to 2010 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Global trends and predictions in hepatocellular carcinoma mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Age-period-cohort models for the Lexis diagram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Flexible regression models with cubic splines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-017-3526-7

Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28785936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs - United States, 2015-2016.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28785936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11605-017-3526-7

1 reference

release_6sg26osuwvhc7nampueytc3eji

5 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6sg26osuwvhc7nampueytc3eji

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference